JPS6248674B2 - - Google Patents

Info

Publication number
JPS6248674B2
JPS6248674B2 JP56116320A JP11632081A JPS6248674B2 JP S6248674 B2 JPS6248674 B2 JP S6248674B2 JP 56116320 A JP56116320 A JP 56116320A JP 11632081 A JP11632081 A JP 11632081A JP S6248674 B2 JPS6248674 B2 JP S6248674B2
Authority
JP
Japan
Prior art keywords
group
desoxy
dianhydro
nitrate
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56116320A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5758692A (en
Inventor
Klaus Klessing
Shyam Sunder Chatterjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Publication of JPS5758692A publication Critical patent/JPS5758692A/ja
Publication of JPS6248674B2 publication Critical patent/JPS6248674B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP56116320A 1980-07-25 1981-07-24 Purine base-substituted alkylaminodesoxy- 1,4;3,6-dianhydrohexitol nitrate, manufacture and medicinal composition Granted JPS5758692A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803028272 DE3028272A1 (de) 1980-07-25 1980-07-25 Durch purinbasen substituierte alkylamino-desoxy-1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
JPS5758692A JPS5758692A (en) 1982-04-08
JPS6248674B2 true JPS6248674B2 (enExample) 1987-10-15

Family

ID=6108125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56116320A Granted JPS5758692A (en) 1980-07-25 1981-07-24 Purine base-substituted alkylaminodesoxy- 1,4;3,6-dianhydrohexitol nitrate, manufacture and medicinal composition

Country Status (9)

Country Link
US (1) US4542137A (enExample)
EP (1) EP0044927B1 (enExample)
JP (1) JPS5758692A (enExample)
AR (1) AR231141A1 (enExample)
AT (1) ATE10498T1 (enExample)
CA (1) CA1186687A (enExample)
DE (1) DE3028272A1 (enExample)
ES (1) ES503485A0 (enExample)
MX (1) MX157614A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate
DE3704604A1 (de) * 1987-02-13 1988-08-25 Mack Chem Pharm Oximether von 2,6-dioxabicyclo(3.3.0)octanonen, herstellungsverfahren und anwendung als arzneimittel
CA2014520C (en) * 1989-04-17 1996-07-16 Fumio Suzuki Hexitol derivatives
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852507A (en) * 1955-02-23 1958-09-16 Eastman Kodak Co Method of preparing powdered salt-free cellulose acetate-dicarboxylates
DE1095285B (de) * 1956-09-25 1960-12-22 Chemiewerk Homburg Zweignieder Verfahren zur Herstellung von basisch substituierten Alkylxanthin-Derivaten
DE1221641B (de) * 1962-03-30 1966-07-28 Degussa Verfahren zur Herstellung von basisch substituierten Theophyllinderivaten
DE1545634A1 (de) * 1965-10-15 1969-08-07 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Adenosin-Ketalen
DE1545635A1 (de) * 1965-10-16 1969-08-07 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Adenosin-Derivaten
US3886186A (en) * 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
GB1356374A (en) * 1971-04-29 1974-06-12 American Home Prod Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol
US4000137A (en) * 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
US4087603A (en) * 1976-09-27 1978-05-02 Eli Lilly And Company Antifungal antibiotics
US4065488A (en) * 1977-02-24 1977-12-27 American Home Products Corporation Process for preparing 1,4:3,6-dianhydro-D-glucitol 2-nitrate
JPS55113786A (en) * 1979-02-23 1980-09-02 Toyo Jozo Co Ltd Novel substance, nepranosin b or f and its preparation
DE3028288A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Gegebenenfalls n-substituierte aminodesoxy-1.4;3.6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und deren verwendung

Also Published As

Publication number Publication date
DE3028272C2 (enExample) 1990-09-13
US4542137A (en) 1985-09-17
DE3028272A1 (de) 1982-02-25
ES8301239A1 (es) 1982-11-16
AR231141A1 (es) 1984-09-28
ATE10498T1 (de) 1984-12-15
EP0044927B1 (de) 1984-11-28
CA1186687A (en) 1985-05-07
JPS5758692A (en) 1982-04-08
MX157614A (es) 1988-12-06
EP0044927A1 (de) 1982-02-03
ES503485A0 (es) 1982-11-16

Similar Documents

Publication Publication Date Title
US4479951A (en) 1.4;3.6-Dianhydrohexitol nitrates substituted by purine bases, processes for their preparation and pharmaceutical compositions
FI89921B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara tertiaera hydroxialkylxantiner
EP1319003B1 (en) Xanthine phosphodiesterase v inhibitors
JPH03204880A (ja) 縮合プリン誘導体
JPS61246184A (ja) ジアンヒドロヘキシツト誘導体、その製造方法およびその医薬としての用途
US8349848B2 (en) Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors
AU2007261568A1 (en) Substituted 8-[6-amino-3-pyridyl]xanthines
JPS6248674B2 (enExample)
JPH0222075B2 (enExample)
HU198933B (en) Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient
US4364953A (en) 2-0- and 5-0-Substituted 1.4;3.6-dianhydrohexitol mononitrates and pharmaceutical composition
JPS63297383A (ja) １，４：３，６‐ジアンヒドロソルビトール　２‐モノニトレート　及び　５‐ニトロレートエステル、これらエステルの製造方法、及びこれらエステルからなる薬剤組成物
CA1051900A (en) 1-hydroxymethyl-1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizine compounds
JPS637550B2 (enExample)
JPH02115178A (ja) 新規な２，３―ジヒドロ―３―アリールアルキルアミノアルキル―４ｈ―１，３―ベンゾキサジン―４―オンの誘導体、その製法、および治療に有用な医薬品
US5120737A (en) Hexitol derivatives
JPH06247942A (ja) ピペラジン誘導体
DE3741005A1 (de) Aminopropanol-derivate von 1,4:3,6-dianhydro-hexit-nitraten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JP2843671B2 (ja) キサンチン誘導体
RU2333212C1 (ru) ПРОИЗВОДНЫЕ 1-И 7-[ω-(БЕНЗГИДРИЛ-4-ПИПЕРАЗИНИЛ-1)АЛКИЛ]-3-АЛКИЛКСАНТИНОВ, ОБЛАДАЮЩИЕ ПРОТИВОГИСТАМИННОЙ И АНТИАЛЛЕРГИЧЕСКОЙ АКТИВНОСТЬЮ
JPWO1992006976A1 (ja) キサンチン誘導体
JPS61152672A (ja) ジベンズ〔ｂ，ｅ〕オキセピン誘導体および抗アレルギ−剤
JPH04364184A (ja) ヘキシトール誘導体
JPH0383983A (ja) 硝酸エステル誘導体およびそれを含有する血管拡張剤
JPH02191297A (ja) エリプチシングリコシド誘導体